Cardiovascular abnormalities in long-term survivors of childhood malignancy
SE Lipshultz and SE Sallan
JCO Jul 1 1993: 1199–1203. [PDF]
Not yet standard: retinoids versus second primary tumors
SM Lippman and WK Hong
JCO Jul 1 1993: 1204–1207. [PDF]
	Cardiac disease following treatment of Hodgkin's disease in children and adolescents
	SL Hancock, SS Donaldson, and RT Hoppe
	JCO Jul 1 1993: 1208–1215. [Abstract] [PDF]
	Adjuvant treatment of stage I lung cancer with high-dose vitamin A
	U Pastorino, M Infante, M Maioli, G Chiesa, M Buyse, P Firket, N Rosmentz, M Clerici, E Soresi, and M Valente
	JCO Jul 1 1993: 1216–1222. [Abstract] [PDF]
	Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group
	DH Johnson, D Bass, LH Einhorn, J Crawford, CA Perez, A Bartolucci, GA Omura, and FA Greco
	JCO Jul 1 1993: 1223–1229. [Abstract] [PDF]
	Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
	G Giaccone, O Dalesio, GJ McVie, A Kirkpatrick, PE Postmus, JT Burghouts, W Bakker, MG Koolen, CP Vendrik, and KJ Roozendaal
	JCO Jul 1 1993: 1230–1240. [Abstract] [PDF]
	Phase II study of weekly edatrexate as first-line chemotherapy for metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group study
	TA Vandenberg, KI Pritchard, EA Eisenhauer, ME Trudeau, BD Norris, P Lopez, SS Verma, RA Buckman, and A Muldal
	JCO Jul 1 1993: 1241–1244. [Abstract] [PDF]
	Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy
	P Fumoleau, FM Delgado, T Delozier, A Monnier, MA Gil Delgado, P Kerbrat, E Garcia-Giralt, R Keiling, M Namer, and MT Closon
	JCO Jul 1 1993: 1245–1252. [Abstract] [PDF]
	Dose-response relationship of epirubicin-based first-line chemotherapy for advanced breast cancer: a prospective randomized trial
	C Focan, JM Andrien, MT Closon, M Dicato, P Driesschaert, D Focan-Henrard, M Lemaire, JP Lobelle, L Longree, and F Ries
	JCO Jul 1 1993: 1253–1263. [Abstract] [PDF]
	Myocyte cell damage after administration of doxorubicin or mitoxantrone in breast cancer patients assessed by indium 111 antimyosin monoclonal antibody studies
	M Estorch, I Carrio, D Martinez-Duncker, L Berna, G Torres, C Alonso, and B Ojeda
	JCO Jul 1 1993: 1264–1268. [Abstract] [PDF]
	Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas
	JH Edmonson, LM Ryan, RH Blum, JS Brooks, M Shiraki, S Frytak, and DR Parkinson
	JCO Jul 1 1993: 1269–1275. [Abstract] [PDF]
	An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas
	K Antman, J Crowley, SP Balcerzak, SE Rivkin, GR Weiss, A Elias, RB Natale, RM Cooper, B Barlogie, and DL Trump
	JCO Jul 1 1993: 1276–1285. [Abstract] [PDF]
	Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy
	JM Robertson, TS Lawrence, LM Dworzanin, JC Andrews, S Walker, ML Kessler, DJ DuRoss, and WD Ensminger
	JCO Jul 1 1993: 1286–1293. [Abstract] [PDF]
	Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections
	EP Fox, TD Weathers, SD Williams, PJ Loehrer, TM Ulbright, JP Donohue, and LH Einhorn
	JCO Jul 1 1993: 1294–1299. [Abstract] [PDF]
	The importance of bleomycin in combination chemotherapy for good- prognosis germ cell carcinoma. Australasian Germ Cell Trial Group
	JA Levi, D Raghavan, V Harvey, D Thompson, T Sandeman, G Gill, R Stuart-Harris, R Snyder, M Byrne, and Z Kerestes
	JCO Jul 1 1993: 1300–1305. [Abstract] [PDF]
	Mesna compared with continuous bladder irrigation as uroprotection during high-dose chemotherapy and transplantation: a randomized trial
	JM Vose, EC Reed, GC Pippert, JR Anderson, PJ Bierman, A Kessinger, J Spinolo, and JO Armitage
	JCO Jul 1 1993: 1306–1310. [Abstract] [PDF]
	Magnetic resonance imaging in the staging of solitary plasmacytoma of bone
	LA Moulopoulos, MA Dimopoulos, D Weber, L Fuller, HI Libshitz, and R Alexanian
	JCO Jul 1 1993: 1311–1315. [Abstract] [PDF]
	Phase III comparative evaluation of PCNU and carmustine combined with radiation therapy for high-grade glioma
	RP Dinapoli, LD Brown, RM Arusell, JD Earle, JR O'Fallon, JC Buckner, BW Scheithauer, JE Krook, LK Tschetter, and JA Maier
	JCO Jul 1 1993: 1316–1321. [Abstract] [PDF]
	Prolonged administration of low-dose, infusional etoposide in patients with etoposide-sensitive neoplasms: a phase I/II study
	DS Thompson, JD Hainsworth, KR Hande, MC Holzmer, and FA Greco
	JCO Jul 1 1993: 1322–1328. [Abstract] [PDF]
	High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy
	CH Weaver, FR Appelbaum, FB Petersen, R Clift, J Singer, O Press, W Bensinger, J Bianco, P Martin, and C Anasetti
	JCO Jul 1 1993: 1329–1335. [Abstract] [PDF]
	Large-cell and immunoblastic lymphoma of the mediastinum: prognostic features and treatment outcome in 57 patients
	D Kirn, P Mauch, K Shaffer, G Pinkus, MA Shipp, WD Kaplan, N Tung, C Wheeler, CJ Beard, and GP Canellos
	JCO Jul 1 1993: 1336–1343. [Abstract] [PDF]
	Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma
	NL Berinstein, MD Reis, BY Ngan, CA Sawka, HH Jamal, and B Kuzniar
	JCO Jul 1 1993: 1344–1352. [Abstract] [PDF]
	Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission
	FB Petersen, MH Lynch, RA Clift, FR Appelbaum, JE Sanders, WI Bensinger, MC Benyunes, K Doney, A Fefer, and P Martin
	JCO Jul 1 1993: 1353–1360. [Abstract] [PDF]
	Immunophenotypes and karyotypes of leukemic cells in children with Down syndrome and acute lymphoblastic leukemia
	CH Pui, SC Raimondi, MJ Borowitz, VJ Land, FG Behm, DJ Pullen, ML Hancock, JJ Shuster, CP Steuber, and WM Crist
	JCO Jul 1 1993: 1361–1367. [Abstract] [PDF]
	Interferon alfa-2a in advanced renal cell carcinoma: treatment results and survival in 159 patients with long-term follow-up
	LM Minasian, RJ Motzer, L Gluck, M Mazumdar, V Vlamis, and SE Krown
	JCO Jul 1 1993: 1368–1375. [Abstract] [PDF]
	Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment
	NI Weijl, D Van der Harst, A Brand, Y Kooy, S Van Luxemburg, J Schroder, E Lentjes, JJ Van Rood, FJ Cleton, and S Osanto
	JCO Jul 1 1993: 1376–1383. [Abstract] [PDF]
	Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam
	D Razavi, N Delvaux, C Farvacques, F De Brier, C Van Heer, L Kaufman, MP Derde, M Beauduin, and M Piccart
	JCO Jul 1 1993: 1384–1390. [Abstract] [PDF]
	Novel chemotherapeutic agents in the treatment of non-small-cell lung cancer
	RC Lilenbaum and MR Green
	JCO Jul 1 1993: 1391–1402. [Abstract] [PDF]
	Circadian cancer therapy
	WJ Hrushesky and GA Bjarnason
	JCO Jul 1 1993: 1403–1417. [Abstract] [PDF]
	Why women gain weight with adjuvant chemotherapy for breast cancer
	W Demark-Wahnefried, EP Winer, and BK Rimer
	JCO Jul 1 1993: 1418–1429. [Abstract] [PDF]
Therapy-related leukemia: what is the role of 4-epi-doxorubicin?
M Riggi and A Riva
JCO Jul 1 1993: 1430–1431. [PDF]
Epirubicin and the risk of leukemia: not substantiated? International Collaborative Cancer Group Steering Committee
M Marty
JCO Jul 1 1993: 1431–1433. [PDF]
Secondary acute myeloid leukemia in Hispanic children
N Winick, GR Buchanan, and BA Kamen
JCO Jul 1 1993: 1433a. [PDF]
An alternate method to overcoming central venous catheter blockage in patients receiving high-dose fluorouracil and leucovorin
JL Marshall and RJ DeLap
JCO Jul 1 1993: 1433b–1434. [PDF]
Fluorouracil and leucovorin: there is a choice
N Petrelli and YM Rustum
JCO Jul 1 1993: 1434a. [PDF]
Response to "More is not always better: a case for low-dose leucovorin"
S Fischkoff and K Martin
JCO Jul 1 1993: 1434b–1435. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.